Objective: To evaluate the performance of cytotechnologists in assessing the adequacy and accuracy of the preliminary diagnosis for fine-needle aspirates of the liver. Study Design: We retrospectively analyzed 10 years of data and found 589 cases of ultrasound-guided fine-needle aspiration (FNA) of the liver with on-site evaluation of adequacy (OSEA). All the OSEA were performed by the cytopathologist because OSEA of liver FNA is not performed by cytotechnologists at our institution at present. After OSEA, the material was seen by cytotechnologists who rendered an adequacy assessment and preliminary diagnosis. We calculated the adequacy and accuracy statistics and compared the performance of the cytotechnologists with the OSEA and final interpretation. Results: There was no statistically significant difference in adequacy downgrade rate for cytotechnologist versus cytopathologist assessment during the study period (5 vs. 3%, p = 0.06). A total agreement of 88% was noted in overall diagnosis with 97% agreement in malignant cases. Conclusion: Cytotechnologists assess the adequacy of liver FNA accurately and there is therefore potential for them to perform OSEA for liver FNA.

Keywords:
Liver fine-needle aspiration, On-site evaluation of adequacy, Cytotechnologist, Cytopathologist
1.
Harewood GC, Pascual J, Raimondo M, et al: Economic analysis of combined endoscopic and endobronchial ultrasound in the evaluation of patients with suspected non-small cell lung cancer. Lung Cancer 2010;67:366-371.
2.
Khalbuss WE, Teot LA, Monaco SE: Diagnostic accuracy and limitations of fine-needle aspiration cytology of bone and soft tissue lesions. Cancer Cytopathol 2010;118:24-32.
3.
Klapman J, Logrono R, Dye CE, Waxman I: Clinical impact of on-site cytopathology interpretation on endoscopic ultrasound-guided fine needle aspiration. Am J Gastroenterol 2003;98:1289-1294.
4.
Rimm DL, Stastny JF, Rimm EB, Ayer S, Frable WJ: Comparison of the costs of fine-needle aspiration and open surgical biopsy as methods for obtaining a pathologic diagnosis. Cancer 1997;81:51-56.
5.
Ylagan LR, Edmundowicz S, Kasal K, Walsh D, Lu DW: Endoscopic ultrasound-guided fine-needle aspiration cytology of pancreatic carcinoma: a 3-year experience and review of the literature. Cancer 2002;96:362-369.
6.
Saleh HA, Khatib G: Positive economic and diagnostic accuracy impacts of on-site evaluation of fine-needle aspiration biopsies by pathologists. Acta Cytol 1996;40:1227-1230.
7.
Aragon Han P, Olson MT, Fazeli R, Prescott JD, Pai SI, Schneider EB, Tufano RP, Zeiger MA: The impact of molecular testing on the surgical management of patients with thyroid nodules. Ann Surg Oncol 2014;21:1862-1869.
8.
Collins JA, Novak A, Ali SZ, Olson MT: Cytotechnologists and on-site evaluation of adequacy. Korean J Pathol 2013;47:405-410.
9.
Collins BT: Telepathology in cytopathology: challenges and opportunities. Acta Cytol 2013;57:221-232.
10.
Dudas R, VandenBussche C, Baras A, Ali SZ, Olson MT: Inexpensive telecytology solutions that use the Raspberry Pi and the iPhone. J Am Soc Cytopathol 2014;3:49-55.
11.
Olson MT, Tatsas AD, Ali SZ: Cytotechnologist-attended on-site adequacy evaluation of thyroid fine-needle aspiration: comparison with cytopathologists and correlation with the final interpretation. Am J Clin Pathol 2011;138:90-95.
12.
Olson MT, Ali SZ: Cytotechnologist on-site evaluation of pancreas fine-needle aspiration adequacy: comparison with cytopathologists and correlation with the final interpretation. Acta Cytol 2012;56:340-346.
13.
Olson MT, Novak A, Boonyaarunnate T, Shahid H, Kirby J, Ali SZ: Cytotechnologist-attended on-site evaluation of adequacy for fine-needle aspiration of bone and soft tissue neoplasms. J Am Soc Cytopathol 2014;3:60-66.
14.
Olson MT, Novak A, Kirby J, Shahid H, Boonyaarunnate T, Ali SZ: Cytotechnologist-attended on-site evaluation of adequacy for metastatic disease involving bone and soft tissue. Acta Cytol 2013;57:550-556.
15.
Wee A: Fine-needle aspiration biopsy of hepatocellular carcinoma and hepatocellular nodular lesions: role, controversies and approach to diagnosis. Cytopathology 2011;22:287-305.
16.
Fisher RA: The logic of inductive inference. J R Statist Soc 1935;98:39-82.
17.
Wotruba AL, Stewart J, Scheberl T, Selvaggi SM: Added value, decreased cost: the evolving role of the cytotechnologist for preliminary screening and triage of thyroid aspirates. Diagn Cytopathol 2011;39:896-899.
18.
Burlingame OO, Kessé KO, Silverman SG, Cibas ES: On-site adequacy evaluations performed by cytotechnologists: correlation with final interpretations of 5,241 image-guided fine-needle aspiration biopsies. Cancer Cytopathol 2012;120:177-184.
© 2014 S. Karger AG, Basel
2014
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.